Abstract |
Cyclophosphamide (CPA) has efficacy as a breast cancer therapy. However, toxicity to CPA limits its clinical applications. Hence there is a need to develop compounds that may be combined with it to improve the efficacy and overcome toxicity. We showed previously that Resveratrol (RES), a chemopreventive agent, increased the growth inhibitory effect of CPA-treated MCF-7 cells. Here we have explored the molecular basis of 5 mM CPA and 50 μM RES as a combination on cell-cycle progression, apoptosis and oxidative stress in MCF-7 breast cancer cells. Efficacy of the combination was also evaluated in a serum-free tumor explant culture model. The combination elicited enhanced anti-proliferative action coupled with differential expression of cell-cycle, apoptosis and stress factors. Furthermore, co-treatment superiority in histologically validated ER positive breast cancer explants suggests that this combination may be a worthy future clinical anti-neoplastic regimen.
|
Authors | Neetu Singh, Manisha Nigam, Vishal Ranjan, Deeba Zaidi, Vivek Kumar Garg, Sharad Sharma, Rashmi Chaturvedi, Rishi Shankar, Sadan Kumar, Ramesh Sharma, Kalyan Mitra, Anil K Balapure, Srikanta K Rath |
Journal | Cancer science
(Cancer Sci)
Vol. 102
Issue 5
Pg. 1059-67
(May 2011)
ISSN: 1349-7006 [Electronic] England |
PMID | 21276137
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2011 Japanese Cancer Association. |
Chemical References |
- Stilbenes
- Cyclophosphamide
- Resveratrol
|
Topics |
- Antineoplastic Combined Chemotherapy Protocols
(pharmacology)
- Apoptosis
(drug effects)
- Blotting, Western
- Breast Neoplasms
(drug therapy, pathology, ultrastructure)
- Cell Cycle
(drug effects)
- Cell Line, Tumor
- Chemotherapy, Adjuvant
- Cyclophosphamide
(administration & dosage)
- Female
- Humans
- Immunoprecipitation
- Microscopy, Electron, Transmission
- Middle Aged
- Oxidative Stress
(drug effects)
- Resveratrol
- Stilbenes
(administration & dosage)
- Tumor Cells, Cultured
|